User profiles for Philip A. Kalra

Philip Kalra

Professor of Nephrology, Salford Royal and University of Manchester
Verified email at manchester.ac.uk
Cited by 16022

[HTML][HTML] Safety and efficacy of NVX-CoV2373 Covid-19 vaccine

…, S Iyengar, A Jamal, C Jeanes, PA Kalra… - … England Journal of …, 2021 - Mass Medical Soc
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…

Serum phosphorus levels associate with coronary atherosclerosis in young adults

…, CA Herzog, A Ishani, PA Kalra - Journal of the …, 2009 - journals.lww.com
Phosphorus levels correlate with atherosclerosis in both animal models and humans with
advanced chronic kidney disease, but whether this relationship exists among individuals with …

[HTML][HTML] Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis

PA Kalra, H Guo, AT Kausz, DT Gilbertson, J Liu… - Kidney international, 2005 - Elsevier
… Author links open overlay panel Philip A. Kalra , Haifeng Guo , Annamaria T. Kausz , David
T. Gilbertson , Jiannong Liu , Shu-Cheng Chen , Areef Ishani , Allan J. … O'Riordan, PA Kalra

[HTML][HTML] Intravenous iron in patients undergoing maintenance hemodialysis

…, S Bhandari, K Farrington, PA Kalra… - … England Journal of …, 2019 - Mass Medical Soc
Background Intravenous iron is a standard treatment for patients undergoing hemodialysis,
but comparative data regarding clinically effective regimens are limited. Methods In a …

Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study

RN Foley, AJ Collins, A Ishani, PA Kalra - American heart journal, 2008 - Elsevier
BACKGROUND: Calcium-phosphate levels, linked to vascular dysfunction in chronic kidney
disease, may represent novel risk factors for coronary heart disease, stroke, and death in …

Serum phosphate and mortality in patients with chronic kidney disease

…, DJ O'Donoghue, RJ Middleton, PA Kalra - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Higher phosphate is associated with mortality in dialysis patients
but few prospective studies assess this in nondialysis patients managed in an outpatient …

The unrecognized prevalence of chronic kidney disease in diabetes

…, P McElduff, JM Gibson, PA Kalra… - Nephrology Dialysis …, 2006 - academic.oup.com
Background. Diabetes mellitus and chronic kidney disease (CKD) are common and exhibit
synergistic associations with premature mortality. Current diabetes guidelines in the UK …

[HTML][HTML] Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference

…, KL Johansen, K Kalantar-Zadeh, PA Kalra… - Kidney international, 2016 - Elsevier
Before the introduction of erythropoiesis-stimulating agents (ESAs) in 1989, repeated transfusions
given to patients with end-stage renal disease caused iron overload, and the need for …

[HTML][HTML] Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis

…, G Wu, MA Sparks, SR Smith, NJA Webb, PA Kalra… - Kidney international, 2014 - Elsevier
Focal segmental glomerulosclerosis (FSGS) is a histological lesion with many causes,
including inherited genetic defects, with significant proteinuria being the predominant clinical …

High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization

…, N Chalmers, RN Foley, PA Kalra - American journal of …, 2014 - Elsevier
Background Current trial data may not be directly applicable to patients with the highest risk
presentations of atherosclerotic renovascular disease, including flash pulmonary edema, …